NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term SNDX stockholder please contact Justin Kuehn, Esq. here, by email at [email protected], or call (833) 672-0814. The consu ...

Quantum Computing Industry - Quantum computing stocks IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing (QUBT) experienced significant declines following Nvidia CEO Jensen Huang's comments that quantum computing technology will not be "very useful" for 15-30 years [1] - Jensen Huang stated that a 15-year timeline for useful quantum computers would be on the early side, while 30 years would be on the late side, with 20 years being a more widely accepted estimate [2] - Quantum computing stocks had previously surged after Google parent Alphabet (GOOGL) announced a chip breakthrough in early December [2] Stock Performance - IonQ stock dropped 10.75%, Rigetti stock and Quantum Computing stock fell 12.9%, and D-Wave Quantum stock declined 14.1% following Huang's remarks [3] - Google stock remained relatively unchanged during the same period [3]

FORT WORTH, Texas, Jan. 7, 2025 /PRNewswire/ -- Kimbell Royalty Partners, LP (NYSE: KRP) ("Kimbell") today announced the pricing of its upsized public offering of 10,000,000 common units representing limited partner interests, at a public offering price of $14.90 per common unit. The total gross proceeds of the offering, before underwriters' discounts and estimated offering expenses, will be approximately $149.0 million. Kimbell has granted the underwriters an option to purchase up to 1,500,000 additional c ...

RADNOR, Pa., Jan. 7, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Wolfspeed, Inc. ("Wolfspeed") (NYSE: WOLF) on behalf of those who purchased or otherwise acquired Wolfspeed securities between August 16, 2023, and November 6, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is January 17, 2025.CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:     If you suffered Wolfspeed los ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired BioAge securities pursuant and/or traceable to BioAge’s registration statement for the initial public offering hel ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired BioAge securities pursuant and/or traceable to BioAge’s registration statement for the initial public offering hel ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX), Sun Communities (NYSE: SUI), Cassava Sciences, Inc (NASDAQ: SAVA), and MGP Ingredients, Inc. (NASDAQ: MGPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:RVNC) in the United States District Court for the Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the “Class Period”) ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Joint Stock Company Kaspi.kz (NASDAQ:KSPI), Applied Therapeutics, Inc. (NASDAQ:APLT), Nextracker Inc. (NASDAQ:NXT), and Transocean Ltd. (NYSE: RIG). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at th ...

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Aehr Test Systems, Inc. (NASDAQ: AEHR), Five9, Inc. (NASDAQ:FIVN), DMC Global Inc. (NASDAQ: BOOM), and Marqeta, Inc. (NASDAQ:MQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Ae ...